Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II

This study has been completed.
Sponsor:
Collaborator:
National Human Genome Research Institute (NHGRI)
Information provided by:
National Institute on Aging (NIA)
ClinicalTrials.gov Identifier:
NCT00089882
First received: August 17, 2004
Last updated: July 22, 2009
Last verified: July 2009